Lastra, Guido <br/><br/>
Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat.  [electronic resource] 

 -  American journal of physiology. Endocrinology and metabolism  Jul 2008 
 - E110-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0193-1849 
<br/><br/><label>Standard No.: </label>10.1152/ajpendo.00258.2007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--metabolism<br/>Animals<br/>Animals, Genetically Modified<br/>Blood Pressure--drug effects<br/>Glucose--metabolism<br/>Glucose Tolerance Test<br/>Glucose Transporter Type 4--metabolism<br/>Immunohistochemistry<br/>Insulin Receptor Substrate Proteins<br/>Insulin Resistance--physiology<br/>Mineralocorticoid Receptor Antagonists--pharmacology<br/>Muscle, Skeletal--drug effects<br/>NADPH Oxidases--metabolism<br/>Oxidative Stress--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Random Allocation<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reactive Oxygen Species--metabolism<br/>Spironolactone--pharmacology